New Delhi, India, February 14, 2015 --(PR.com
)-- DelveInsight, a Market Research & Business Consulting firm, has started a promotional offer on its Gene therapy reports highlighting their on-going demand across the globe. These reports provide detailed insight for 15 Therapy areas covering more than 300 gene therapies along with the companies involved.
DelveInsight’s new report series on gene therapy is like none other currently in the market. Apart from the information on drug pipeline and competitive landscape, reports in these series include extensive information on gene therapy technologies and analysis of the therapy molecules. Titled Gene Therapy Insights: Pipeline Assessment – Technology and Competitive landscape, these report series provide their clients a map of the entire drug development territory.
Keeping with its aim of providing the affordable and comprehensive industry coverage to its clients DelveInsight is offering its Gene Therapy reports at a promotional price of USD 6,000 (Single User License), 10,000 (Site License) and 14,000 (Global/Enterprise License). These reports examine the entire market of gene therapy, current progress of competitive products, details of technologies, active ingredients and regulatory success of gene therapies and early market winners in place.
Please contact firstname.lastname@example.org if you would like to take advantage of our limited period promotional offer.